Investing Profile

Alan Crane

VC
Photo of Alan Crane, Partner at Polaris Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
34
$4B
CompanyStageDateRound SizeTotal Raised
Tome Biosciences
Series ADec 2023$210M
$210M
Co-investors: Daniel Lynch (GV (Google Ventures)), Jorge Conde (Andreessen Horowitz), Jay Markowitz (ARCH Venture Partners)
Seismic Therapeutic
Series BDec 2023$120M
Series AFeb 2022$100M
$220M
Co-investors: Andrew Hedin (Bessemer Venture Partners), Timothy A. Springer
Dyno Therapeutics
Series AMay 2021$100M
SeedMay 2020$9M
$110M
Co-investors: Dylan Morris (Insight Partners), Jorge Conde (Andreessen Horowitz)
Pandion Therapeutics
Series AJan 2018$58M
$140M
Co-investors: Carlo Rizzuto (Versant Ventures), Vikas Goyal (SR One), Dan Becker (Access Biotechnology)
YourBio Health
Series CNov 2016$10M
Series BAug 2014$16M
Series AJun 2012$10M
Series AMay 2011$5M
$41M
Co-investors: Doug Cole (Flagship Ventures)
Navitor Pharmaceuticals
Series BDec 2015$33M
Series AJun 2014$24M
$57M
T2 Biosystems
Series EMar 2013$40M
Series DAug 2011$23M
Series CMay 2010$15M
Series BOct 2008$11M
Series AJan 2006$6M
$96M
Co-investors: Harry Wilcox (Flagship Pioneering), Michael Greeley (Flare Capital Partners), Josh Bilenker (Aisling Capital), Stacy Feld (Johnson & Johnson Innovation)
Cerulean Pharma
Private EquityDec 2012$13M
Series DDec 2011$15M
Series CNov 2010$24M
Series BJul 2009$10M
Series BJan 2008$8M
Series AMay 2007$12M
Series UnknownDec 2006$2M
$98M
Co-investors: Bryan Roberts (Venrock), Martin Alexander Gershon (Endeavor Venture Funds)